Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

23 trials with published results (12%)

Research Maturity

89 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.9%

11 terminated out of 187 trials

Success Rate

89.0%

+2.4% vs benchmark

Late-Stage Pipeline

7%

14 trials in Phase 3/4

Results Transparency

26%

23 of 89 completed with results

Key Signals

23 with results89% success11 terminated

Data Visualizations

Phase Distribution

96Total
Not Applicable (48)
Early P 1 (5)
P 1 (17)
P 2 (12)
P 3 (5)
P 4 (9)

Trial Status

Completed89
Recruiting36
Unknown22
Terminated11
Not Yet Recruiting11
Active Not Recruiting10

Trial Success Rate

89.0%

Benchmark: 86.6%

Based on 89 completed trials

Clinical Trials (187)

Showing 20 of 20 trials
NCT07755813Phase 2Not Yet RecruitingPrimary

Pirfenidone as Treatment of Chronic Pancreatitis

NCT06362187Not ApplicableNot Yet RecruitingPrimary

VR Pilot for Pancreatitis

NCT05664880Early Phase 1Active Not RecruitingPrimary

A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis

NCT05771675Early Phase 1Recruiting

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

NCT03324698Active Not RecruitingPrimary

The Natural History of Chronic Pancreatitis

NCT06386224Not ApplicableRecruiting

Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

NCT07707609RecruitingPrimary

Neural Sensitisation and Neuropsychological Alterations in Painful Chronic Pancreatitis

NCT07696572Recruiting

EUS Procedures Using RIVOS™ EUS Access Device

NCT07285863Phase 4Recruiting

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

NCT07670871Not Yet Recruiting

Exocrine-Endocrine Pancreatic Crosstalk: Precision Pathways to Reframe Diabetes Pathophysiology

NCT05603702Phase 1Active Not Recruiting

STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis

NCT07621029Not Yet Recruiting

Venous Resection in Patients Undergoing Pancreatic Surgery

NCT03460769Recruiting

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

NCT07612566Not Yet RecruitingPrimary

Immune Repertoire Decoding for Chronic Pancreatitis-to-Pancreatic Cancer Risk Stratification

NCT07536841Recruiting

Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis

NCT07559448Not ApplicableNot Yet RecruitingPrimary

Palatable Elemental Diet for Gastrointestinal Symptoms in Chronic Pancreatitis

NCT07223554Not ApplicableCompletedPrimary

A Tailored, Web-Based Self-Management Program to Treat Pain in Chronic Pancreatitis

NCT07418593Phase 4RecruitingPrimary

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

NCT06205342Early Phase 1RecruitingPrimary

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

NCT05095532Phase 1RecruitingPrimary

Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

Scroll to load more

Research Network

Activity Timeline